The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis

AIMS: Treatment with vitamin D sterols can lower plasma parathyroid hormone (PTH) in patients with secondary hyperparathyroidism; however, hypercalcaemia, hyperphosphataemia, or both, often develop. Calcimimetic agents, employed in alternative therapeutic approaches, directly inhibit PTH secretion b...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Ohashi, Naro, Uematsu, Toshihiko, Nagashima, Satoru, Kanamaru, Mitsutaka, Togawa, Akashi, Hishida, Akira, Uchida, Eiji, Akizawa, Tadao, Koshikawa, Shozo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Blackwell Science Inc 2004
Aiheet:
Pharmacodynamics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884513/
https://ncbi.nlm.nih.gov/pubmed/15151518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2004.02088.x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia